First Time Loading...

Repligen Corp
NASDAQ:RGEN

Watchlist Manager
Repligen Corp Logo
Repligen Corp
NASDAQ:RGEN
Watchlist
Price: 158.36 USD -3.56% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one RGEN stock under the Base Case scenario is 99.2 USD. Compared to the current market price of 158.36 USD, Repligen Corp is Overvalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RGEN Relative Value
Base Case
99.2 USD
Overvaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

13.8
P/S
P/S
Price to Sales
13.8
vs History
66
vs Industry
16
Median 3Y
14.5
Median 5Y
16.7
Industry
3.9
Forward
13.6
More Details
212.4
P/E
P/E
Price to Earnings
212.4
vs History
19
vs Industry
0
Median 3Y
76.6
Median 5Y
136.9
Industry
30.3
Forward
106.5
More Details
77.5
P/OCF
P/OCF
Price to OCF
77.5
vs History
57
vs Industry
5
Median 3Y
81.1
Median 5Y
83.9
Industry
23.2
More Details
118.9
P/FCFE
P/FCFE
Price to FCFE
118.9
vs History
58
vs Industry
6
Median 3Y
175.8
Median 5Y
144.8
Industry
26.9
More Details
4.5
P/B
P/B
Price to Book Value
4.5
vs History
82
vs Industry
22
Median 3Y
5.6
Median 5Y
5.5
Industry
2.5
More Details
13.4
EV/S
EV/S
Enterprise Value to Sales
13.4
vs History
63
vs Industry
14
Median 3Y
14.1
Median 5Y
15.8
Industry
3.8
Forward
13.2
More Details
27.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
27.2
vs History
55
vs Industry
12
Median 3Y
25.9
Median 5Y
29.5
Industry
7.7
More Details
55.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
55.5
vs History
58
vs Industry
6
Median 3Y
49.1
Median 5Y
64.3
Industry
16.8
Forward
71.4
More Details
99
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
99
vs History
42
vs Industry
4
Median 3Y
67.6
Median 5Y
95.2
Industry
22
Forward
97.3
More Details
75.4
EV/OCF
EV/OCF
Enterprise Value to OCF
75.4
vs History
50
vs Industry
5
Median 3Y
79
Median 5Y
79
Industry
21.1
More Details
114.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
114.6
vs History
65
vs Industry
6
Median 3Y
166.2
Median 5Y
142.3
Industry
27.6
More Details
4.2
EV/IC
EV/IC
Enterprise Value to IC
4.2
vs History
88
vs Industry
23
Median 3Y
5.2
Median 5Y
5.3
Industry
2.4
More Details

Multiples Across Competitors

RGEN Competitors Multiples
Repligen Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Repligen Corp
NASDAQ:RGEN
8.8B USD 13.8 212.4 55.5 99
US
Thermo Fisher Scientific Inc
NYSE:TMO
222.3B USD 5.2 37.1 22.9 33.6
US
Danaher Corp
NYSE:DHR
182.8B USD 4.2 22.7 16.5 20.3
US
IQVIA Holdings Inc
NYSE:IQV
42.3B USD 2.8 31.1 16.9 26.1
US
Agilent Technologies Inc
NYSE:A
40.6B USD 6 32.9 26.3 31.6
KR
Samsung Biologics Co Ltd
KRX:207940
55.4T KRW 15 64.6 34 49
CH
Lonza Group AG
SIX:LONN
37.3B CHF 5.5 57.1 19.6 28.7
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.1 23.8 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.5B USD 9.1 46.7 32.4 39.3
IE
ICON PLC
NASDAQ:ICLR
24.9B USD 3 36.5 16.5 25.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
19B EUR 7 74.6 32.1 52.7

See Also

Summary
RGEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
RGEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RGEN stock valuation using valuation multiples.
Wall Street Estimates
RGEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RGEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.